A citation-based method for searching scientific literature




Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
Times Cited: 130




List of shared articles



Times cited

The Ambulatory Glucose Profile: Opportunities for Enhancement.
David Rodbard. Diabetes Technol Ther 2021
4

Standardized Hybrid Closed-Loop System Reporting.
Viral N Shah, Satish K Garg. Diabetes Technol Ther 2021
3

Time-in-range for monitoring glucose control: Is it time for a change?
Virginia Bellido, Pedro José Pinés-Corrales, Rocío Villar-Taibo, Francisco Javier Ampudia-Blasco. Diabetes Res Clin Pract 2021
0


American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
George Grunberger, Jennifer Sherr, Myriam Allende, Thomas Blevins, Bruce Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, Victor Lawrence Roberts, David Rodbard,[...]. Endocr Pract 2021
7

Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections.
Sara Hallström, Irl B Hirsch, Magnus Ekelund, Sheyda Sofizadeh, Henrik Albrektsson, Solveig Dahlqvist, Ann-Marie Svensson, Marcus Lind. Diabetes Technol Ther 2021
1

Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?
Chiara Fabris, Lutz Heinemann, Roy Beck, Claudio Cobelli, Boris Kovatchev. Diabetes Technol Ther 2020
15

THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Simon Helleputte, Tine De Backer, Patrick Calders, Bart Pauwels, Samyah Shadid, Bruno Lapauw. Endocr Pract 2021
1

Patient-Tailored Decision Support System Improves Short- and Long-Term Glycemic Control in Type 2 Diabetes.
Petra Augstein, Peter Heinke, Lutz Vogt, Klaus-Dieter Kohnert, Eckhard Salzsieder. J Diabetes Sci Technol 2021
0

Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study.
Jingyi Lu, Chunfang Wang, Yun Shen, Lei Chen, Lei Zhang, Jinghao Cai, Wei Lu, Wei Zhu, Gang Hu, Tian Xia,[...]. Diabetes Care 2021
23

Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities.
Satish K Garg, David Rodbard, Irl B Hirsch, Gregory P Forlenza. Diabetes Technol Ther 2020
73



The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring.
Gonzalo Díaz-Soto, M Pilar Bahíllo-Curieses, Rebeca Jimenez, Maria de la O Nieto, Emilia Gomez, Beatriz Torres, Juan Jose López Gomez, Daniel de Luis. Endocrinol Diabetes Nutr 2021
2